pharma news today obesity drug glp-1 updates Major global in July 2026 feature massive market Poll: 1 in 8 Adults

Prevalence of chronic obstructive pulmonary disease and chronic bronchitis in eight countries: a systematic review and meta-analysis

Ho, KKY, Hoffman,DM

Qu inters tiene el cido hidroxictrico (HCA)

Diabetes Ther (2021) 12:320115

Education initiatives aimed at promoting understanding of type 2 diabetes and obesity, combined with successful outcomes from GLP-1 therapies, are leading to higher prescription rates

The comorbid conditions of Fragile X syndrome, tuberous sclerosis, phenylketonuria, or fetal alcohol syndrome were excluded because these children present some autistic behavioral features, but the origin is known